Valuation: Takeda Pharmaceutical Company Limited

Market Cap 8,467B 52.5B 45.89B 42.17B 39.31B 74.56B 4,998B 75.69B 506B 197B 2,457B 197B 193B P/E 2027 *
43.6x
P/E 2028 * 27.9x
Enterprise Value 12,352B 76.59B 66.95B 61.53B 57.35B 109B 7,292B 110B 739B 287B 3,585B 287B 281B EV / Sales 2027 *
2.67x
EV / Sales 2028 * 2.6x
Free-Float
99.25%
Yield 2027 *
3.81%
Yield 2028 * 3.89%
1 day+1.61%
1 week+5.35%
Current month+3.96%
1 month+10.49%
3 months-7.64%
6 months+10.84%
Current year+10.84%
1 week 5,100
Extreme 5100
5,515
1 month 4,896
Extreme 4896
5,515
Current year 4,710
Extreme 4710
6,033
1 year 4,102
Extreme 4102
6,033
3 years 3,852
Extreme 3852
6,033
5 years 2,993
Extreme 2993
6,033
10 years 2,894.5
Extreme 2894.5
6,693
Manager TitleAgeSince
Chief Executive Officer - 24/06/2026
Director of Finance/CFO 48 01/04/2024
Chief Tech/Sci/R&D Officer 47 01/02/2022
Director TitleAgeSince
Director/Board Member 60 01/06/2015
Director/Board Member 73 01/01/2019
Director/Board Member 48 01/06/2024
Date Insider Type Main position Quantity % Market Cap.
04-27Free

Chief Technology Officer

212,470 0.0134%
04-27Free

Chief Financial Officer

15,614 0.0010%
04-27Free

Chief Executive Officer

323,248 0.0203%
Change 5-day change 1-year change 3-year change Capi.($)
+1.61%+5.35%+20.70%+18.61% 52.5B
+1.86%+0.48%+55.50%+163.08% 1,082B
+3.57%+3.29%+68.60%+61.03% 633B
+3.99%+3.05%+37.93%+93.37% 461B
+3.86%+1.64%+31.35%+24.29% 338B
-0.56%+0.96%+39.86%+36.64% 299B
-0.08%+1.30%+30.37%+44.02% 291B
-1.54%+2.81%-27.56%-39.45% 222B
+3.55%+4.41%+25.45%+66.28% 202B
+4.21%+2.65%+17.47%+71.11% 163B
Average +2.05%+4.66%+29.97%+53.90% 374.49B
Weighted average by Cap. +2.24%+5.53%+41.48%+82.10%

Financials

2027 *2028 *
Net sales 4,630B 28.71B 25.1B 23.07B 21.5B 40.78B 2,734B 41.4B 277B 108B 1,344B 108B 105B 4,701B 29.15B 25.48B 23.42B 21.83B 41.4B 2,775B 42.03B 281B 109B 1,364B 109B 107B
Net income 184B 1.14B 997M 916M 854M 1.62B 109B 1.64B 11B 4.28B 53.37B 4.28B 4.19B 309B 1.92B 1.68B 1.54B 1.44B 2.72B 183B 2.77B 18.5B 7.19B 89.76B 7.2B 7.04B
Net Debt 3,886B 24.09B 21.06B 19.36B 18.04B 34.22B 2,294B 34.74B 232B 90.33B 1,128B 90.43B 88.49B 3,750B 23.25B 20.33B 18.68B 17.41B 33.03B 2,214B 33.53B 224B 87.19B 1,088B 87.29B 85.41B
Logo Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Employees
47,029
Date Price Change Volume
03/07/26 ¥5,359.00 +1.61% 4,074,200
02/07/26 ¥5,274.00 +2.41% 3,538,100
01/07/26 ¥5,150.00 -0.10% 4,177,200
30/06/26 ¥5,155.00 -0.41% 4,329,100
29/06/26 ¥5,176.00 +1.75% 7,388,100
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,359.00JPY
Average target price
6,106.87JPY
Spread / Average Target
+13.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 4502 Stock